Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
暂无分享,去创建一个
A. Gonçalves | K. Geboes | P. Lago | A. Falcão | F. Carneiro | F. Magro | J. Soares | A. Vieira | P. Caldeira | P. Ministro | J. Lopes | P. Andrade | C. Dias | I. Rosa | R. Coelho | J. Moleiro | S. Lopes | P. Sousa | Helena Tavares de Sousa | D. Carvalho | J. Ramos | T. Meira | R. Gonçalves | J. Afonso